JP2015524808A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524808A5 JP2015524808A5 JP2015524450A JP2015524450A JP2015524808A5 JP 2015524808 A5 JP2015524808 A5 JP 2015524808A5 JP 2015524450 A JP2015524450 A JP 2015524450A JP 2015524450 A JP2015524450 A JP 2015524450A JP 2015524808 A5 JP2015524808 A5 JP 2015524808A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- apolipoprotein
- administered
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675659P | 2012-07-25 | 2012-07-25 | |
| US61/675,659 | 2012-07-25 | ||
| PCT/US2013/052078 WO2014018763A2 (en) | 2012-07-25 | 2013-07-25 | Method of treating type i diabetes using apolipoprotein aiv |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015524808A JP2015524808A (ja) | 2015-08-27 |
| JP2015524808A5 true JP2015524808A5 (enExample) | 2016-08-25 |
Family
ID=48916270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524450A Pending JP2015524808A (ja) | 2012-07-25 | 2013-07-25 | アポリポタンパク質ａｉｖを用いたｉ型糖尿病の治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9730980B2 (enExample) |
| EP (1) | EP2877197A2 (enExample) |
| JP (1) | JP2015524808A (enExample) |
| AU (1) | AU2013295721B2 (enExample) |
| CA (1) | CA2878695A1 (enExample) |
| WO (1) | WO2014018763A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103391786B (zh) | 2011-01-19 | 2016-06-22 | 辛辛那提大学 | 作为抗糖尿病肽的载脂蛋白a-iv |
| CA2860782A1 (en) | 2012-01-19 | 2013-07-25 | Patrick Tso | Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| US10232019B2 (en) | 2012-07-25 | 2019-03-19 | University Of Cincinnati | Method of treating hyperglycemic disorders using apolipoprotein AIV |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| FR2686605B1 (fr) * | 1992-01-27 | 1994-03-11 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides, leur preparation et leur utilisation. |
| WO1994027629A1 (en) | 1993-05-28 | 1994-12-08 | Merck & Co., Inc. | Method to control appetite and treat obesity |
| JP2005502332A (ja) * | 2001-07-26 | 2005-01-27 | ジェンセット ソシエテ アノニム | Ｇｍｇ−２ポリヌクレオチド及びポリペプチド並びにそれらの使用 |
| DE60224064T2 (de) * | 2001-10-05 | 2008-11-20 | Serono Genetics Institute S.A. | Fragmente des humanen zn-alpha2-glykoproteins und deren verwendung in methoden zur behandlung der fettleibigkeit |
| BR0310100A (pt) | 2002-05-17 | 2007-04-27 | Esperion Therapeutics Inc | métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto |
| MXPA06010043A (es) * | 2004-03-01 | 2007-03-07 | Peptimmune Inc | Metodos y composiciones para el tratamiento de enfermedades autoinmunologicas. |
| TW200815377A (en) * | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound |
| US20100267052A1 (en) | 2006-09-01 | 2010-10-21 | American Type Culture Collection | Compositions and methods for diagnosis and treatment of type 2 diabetes |
| AU2009226246A1 (en) | 2008-03-21 | 2009-09-24 | Podiceps B.V. | Diagnostic of pre-symptomatic metabolic syndrome |
| CN103788043B (zh) | 2008-11-28 | 2016-02-03 | 中国医学科学院药物研究所 | 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途 |
| PT2554183T (pt) * | 2009-11-13 | 2018-07-09 | Sanofi Aventis Deutschland | Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina |
| CN103391786B (zh) * | 2011-01-19 | 2016-06-22 | 辛辛那提大学 | 作为抗糖尿病肽的载脂蛋白a-iv |
| CA2860782A1 (en) | 2012-01-19 | 2013-07-25 | Patrick Tso | Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| US10232019B2 (en) | 2012-07-25 | 2019-03-19 | University Of Cincinnati | Method of treating hyperglycemic disorders using apolipoprotein AIV |
-
2013
- 2013-07-25 AU AU2013295721A patent/AU2013295721B2/en not_active Ceased
- 2013-07-25 CA CA2878695A patent/CA2878695A1/en not_active Abandoned
- 2013-07-25 US US14/416,527 patent/US9730980B2/en not_active Expired - Fee Related
- 2013-07-25 JP JP2015524450A patent/JP2015524808A/ja active Pending
- 2013-07-25 WO PCT/US2013/052078 patent/WO2014018763A2/en not_active Ceased
- 2013-07-25 EP EP13745314.8A patent/EP2877197A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011241213A5 (enExample) | ||
| JP2013507439A5 (enExample) | ||
| JP2016539921A5 (enExample) | ||
| FI3506886T3 (fi) | Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä | |
| RU2015147876A (ru) | Пероральная дозированная форма соединений глюкагоноподобного пептида-1 | |
| RU2600440C3 (ru) | Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты | |
| HRP20170358T1 (hr) | Inhibitori histonskih demetilaza | |
| JP2014521684A5 (enExample) | ||
| HRP20251088T1 (hr) | Upotreba dugodjelujućih peptida glp‑1 | |
| JP2016514132A5 (enExample) | ||
| MX2017004592A (es) | Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos. | |
| JP2015518818A5 (enExample) | ||
| HRP20200072T1 (hr) | Načini doziranja za spojeve klase ehinokandina | |
| RU2739037C3 (ru) | Композиция для контролируемой стимуляции яичников | |
| JP2011526886A5 (enExample) | ||
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| JP2011519364A5 (enExample) | ||
| TR201815158T4 (tr) | Selektif glukagon reseptör agonistleri olarak eksendin-4 deriveleri. | |
| JP2013542247A5 (enExample) | ||
| JP2015520188A5 (enExample) | ||
| JP2014504601A5 (enExample) | ||
| JP2014532722A5 (enExample) | ||
| RU2016114098A (ru) | Новое производное аналога инсулина | |
| EA201491513A1 (ru) | Рекомбинантные штаммы escherichia coli | |
| JP2014508758A5 (enExample) |